These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1682579)

  • 1. Pancreatic enzyme supplement dosage in cystic fibrosis.
    Owen G; Peters TJ; Dawson S; Goodchild MC
    Lancet; 1991 Nov; 338(8775):1153. PubMed ID: 1682579
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
    Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
    Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
    Zsíros J; Sólyom E
    Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
    Dutta SK; Tilley DK
    J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.
    Vyas H; Matthew DJ; Milla PJ
    Eur J Pediatr; 1990 Jan; 149(4):241-3. PubMed ID: 1689245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
    Warwick WJ; Budd JR
    Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
    Cho YW; Aviado DM
    J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
    [No Abstract]   [Full Text] [Related]  

  • 9. Malabsorption in cystic fibrosis: mechanisms and treatment.
    Bouquet J; Sinaasappel M; Neijens HJ
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S30-5. PubMed ID: 3404359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
    Henker J; Hoffmann D; Paul D; Hein J; Paditz E
    Fortschr Med; 1993 Feb; 111(4):53-6. PubMed ID: 8449468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does enzyme substitution therapy reduce pain in chronic pancreatitis?].
    Hansen ML; Rumessen JJ
    Ugeskr Laeger; 2005 Apr; 167(17):1841-4. PubMed ID: 15929329
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
    Gow R; Bradbear R; Francis P; Shepherd R
    Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of pancreatic enzyme preparations on erythrocyte glutathione peroxidase activities and plasma selenium concentrations in cystic fibrosis.
    Winklhofer-Roob BM; Tiran B; Tuchschmid PE; van't Hof MA; Shmerling DH
    Free Radic Biol Med; 1998 Jul; 25(2):242-9. PubMed ID: 9667502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic enzyme supplements in cystic fibrosis.
    Morrison G; Morrison J; Redmond A; Byers C; McCracken K; Dodge JA
    Lancet; 1991 Dec 21-28; 338(8782-8783):1596-7. PubMed ID: 1683999
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoalbuminemia at diagnosis as a marker for severe respiratory course in infants with cystic fibrosis identified by newborn screening.
    Abman SH; Reardon MC; Accurso FJ; Hammond KB; Sokol RJ
    J Pediatr; 1985 Dec; 107(6):933-5. PubMed ID: 3851839
    [No Abstract]   [Full Text] [Related]  

  • 17. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.
    Pettei MJ; Leonidas JC; Levine JJ; Gorvoy JD
    J Pediatr; 1994 Oct; 125(4):587-9. PubMed ID: 7931879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK; Hubbard VS; Appler M
    Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
    Morrison G; Morrison JM; Redmond AO; Byers CA; McCracken KJ; Dodge JA; Guilford SA; Bowden MW
    Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Smyth RL; Ashby D; O'Hea U; Burrows E; Lewis P; van Velzen D; Dodge JA
    Lancet; 1995 Nov; 346(8985):1247-51. PubMed ID: 7475715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.